Bio Equity Risk Management has formed as a Boston-based investment firm focused on special situations opportunities in the healthcare industry. The firm’s co-founding managing partners are Nessan Bermingham, a former partner with Omega Funds, and Joseph Siletto, who previously was with Cowen & Company.
Bio Equity Risk Management, LLC, a boutique healthcare investment firm, announced today that it has formed, and opened an office in Boston. The firm was founded by Managing Partner Nessan Bermingham, Ph.D., a scientist with deep venture capital and direct secondary investment experience. He is joined by Managing Partner Joseph Siletto, a 12-year veteran of healthcare investment banking. Bio Equity Risk Management focuses on providing special situation investment solutions for companies, limited partners and general partners in biotechnology, medical device and healthcare IT sectors, across all stages of development.
Bio Equity Risk Management’s managing partners, Nessan Bermingham and Joseph Siletto, bring complementary healthcare investment experience to their new firm. Prior to forming Bio Equity Risk Management, Nessan was a partner at Omega Funds, a direct secondary healthcare fund, where he opened the firm’s Boston office, and led its expansion into the U.S. healthcare market. Prior to joining Omega Funds, Nessan was a partner at Atlas Venture, where he focused on the U.S. public markets and EU private biotech markets. He was also a biopharma research analyst at UBS Warburg. Joseph Siletto was previously a director of health care investment banking at Cowen and Company in Boston, where he advised companies on IPO, follow-on, PIPE and M&A transactions. He was also a principal and co-head of the Life Sciences Group at SVB Alliant, a subsidiary of Silicon Valley Bank, and a Vice President at Banc of America Securities in San Francisco, where he focused on the healthcare sector.
Bio Equity Risk Management has also formed an Advisory Board, which includes industry veterans who provide special investment and science expertise for deal due diligence, structure and pricing, and network development. The Advisory Board’s expertise includes investment and finance strategy, clinical development, drug discovery, regulatory, and commercialization strategies. For more information on the Advisory Board, go to www.bioequityrisk.com.
About Bio Equity Risk Management, LLC
Bio Equity Risk Management, LLC is a boutique healthcare investment firm focused on special situation investments. The firm’s investment approach provides solutions for companies, limited partners and general partners in the healthcare industry. The Bio Equity team is comprised of seasoned healthcare investors and executives who have deep experience across a variety of biotechnology, medical device and healthcare IT sectors, spanning all stages of development. For more information, visit www.bioequityrisk.com.